New-Onset Diabetes in COVID-19: Time to Frame Its Fearful Symmetry Stella PapachristouIliana StamatiouNikolaos Papanas Commentary Open access 26 December 2020 Pages: 461 - 464
Individualizing Time-in-Range Goals in Management of Diabetes Mellitus and Role of Insulin: Clinical Insights From a Multinational Panel Sanjay KalraShehla ShaikhDiana A. Nkansah Review Open access 26 December 2020 Pages: 465 - 485
A Consideration of the Psychological Aspects to Managing Patients with Painful Diabetic Neuropathy: An Insight into Pain Management Services at a Tertiary Centre in the UK Hannah TwiddyBernhard FrankUazman Alam Review Open access 26 December 2020 Pages: 487 - 498
Linear Projection of Estimated Glomerular Filtration Rate Decline with Canagliflozin and Implications for Dialysis Utilization and Cost in Diabetic Nephropathy Michael DurkinJaime Blais Original Research Open access 18 December 2020 Pages: 499 - 508
Comparative Effectiveness of Switching From First-Generation Basal Insulin to Glargine 300 U/ml or Degludec 100 U/ml in Type 1 Diabetes: The RESTORE-1 Study Luigi LaviolaFrancesca Porcellatithe RESTORE-1 Study Group Original Research Open access 22 December 2020 Pages: 509 - 525
Real-World Effectiveness Analysis of Switching From Liraglutide or Dulaglutide to Semaglutide in Patients With Type 2 Diabetes Mellitus: The Retrospective REALISE-DM Study Akshay B. JainSteve KantersSara G. Stafford Original Research Open access 26 December 2020 Pages: 527 - 536
Evaluating the Cost-Effectiveness of Once-Weekly Semaglutide 1 mg Versus Empagliflozin 25 mg for Treatment of Patients with Type 2 Diabetes in the UK Setting Matthew CapehornNino HallénBarnaby Hunt Original Research Open access 09 January 2021 Pages: 537 - 555
Efficacy, Safety, and Immunogenicity of Insulin Aspart Biosimilar SAR341402 Compared with Originator Insulin Aspart in Adults with Diabetes (GEMELLI 1): A Subgroup Analysis by Prior Type of Mealtime Insulin Viral N. ShahEdward FranekKarita Sadeharju Original Research Open access 11 January 2021 Pages: 557 - 568
Long-Term Efficacy and Safety of Ultra Rapid Lispro (URLi) in Adults with Type 1 Diabetes: The PRONTO-T1D Extension Juliana Bue-ValleskeyLeslie KlaffDominik Dahl Original Research Open access 17 January 2021 Pages: 569 - 580
A Retrospective Analysis of Therapeutic Inertia in Type 2 Diabetes Management Across a Diverse Population of Health Care Organizations in the USA Cori R. RattelmanElizabeth L. CieminsJohn K. Cuddeback Original Research Open access 18 January 2021 Pages: 581 - 594
Comparison of Patient-Led and Physician-Led Insulin Titration in Japanese Type 2 Diabetes Mellitus Patients Based on Treatment Distress, Satisfaction, and Self-Efficacy: The COMMIT-Patient Study Hitoshi IshiiHiroki NakajimaDai Shimono Original Research Open access 18 January 2021 Pages: 595 - 611
Effect of Orally Administered Semaglutide Versus Dulaglutide on Diabetes-Related Quality of Life in Japanese Patients with Type 2 Diabetes: The PIONEER 10 Randomized, Active-Controlled Trial Hitoshi IshiiBrian B. HansenHiroshi Horio Brief Report Open access 18 January 2021 Pages: 613 - 623
Correction to: Semaglutide: Charting New Horizons in GLP-1 Analogue Outcome Studies David M. WilliamsMarc Evans Correction Open access 08 January 2021 Pages: 625 - 625
Correction to: The Effects of Mobile-App-Based Low-Carbohydrate Dietary Guidance on Postprandial Hyperglycemia in Adults with Prediabetes Xiaoyu ChenHaihua SuQi Guo Correction Open access 17 January 2021 Pages: 627 - 627